Gary W. Falk M.D., M.S. is currently Professor of Medicine and Director, Esophageal Program, Hospital of the University of Pennsylvania, and University of Pennsylvania Perelman School of Medicine. He received his undergraduate and medical school training at the University of Rochester before going to George Washington University for his medical internship and residency. After GI fellowship at the University of Michigan, he was a member of the Department of Gastroenterology and Hepatology at the Cleveland Clinic for over 23 years. While in Cleveland, he also received a master’s degree in clinical research from Case Western Reserve University.
He has been involved in clinical research in Barrett’s esophagus, gastroesophageal reflux disease, Helicobacter pylori, esophageal motility disorders, advanced esophageal imaging and therapeutics and eosinophilic esophagitis throughout his career. The most important of these themes has been in the area of early detection and prevention of esophageal cancer. Research in eosinophilic esophagitis is now focusing on clinical trials of novel therapeutic agents, clinical and biologic aspects of pediatric to adult transition and participation in the CEGIR consortium.
Dr Falk has served nationally through professional societies, including being a Past-President of the American Society of Gastrointestinal Endoscopy. He is a past associate editor of the American Journal of Gastroenterology and is current associate editor of Diseases of the Esophagus. He is a two-time recipient of the Sidney Cohen University of Pennsylvania GI Fellowship Teacher of the Year Award, AGA Distinguished Clinician Award and AGA Imaging & Advanced Technology Section Research Mentor Award.